JG
ANAC

Joel Greenblatt’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Joel Greenblatt’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-13,741
Closed -$1.06M – 1145
2015
Q2 		$1.06M Buy
+13,741
New +$901K 0.01% 626

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Joel Greenblatt's ANAC Position: Q3 2015 in Review

Joel Greenblatt sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2015, closing a stake of 13,741 shares — an estimated $1.06M sold.

Joel Greenblatt first reported a position in ANAC in Q2 2015 and held it in 1 quarter. The position peaked at $1.06M in Q2 2015. 213 funds tracked by Wall St. Rank hold ANAC as of Q3 2015.

  • Joel Greenblatt reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2015 after selling out during the quarter.
  • Joel Greenblatt sold 13,741 ANACOR PHARMACEUTICALS INC COM shares in Q3 2015, an estimated $1.06M.
  • Joel Greenblatt first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 1 quarter.
  • Joel Greenblatt's ANACOR PHARMACEUTICALS INC COM position peaked at $1.06M in Q2 2015.
  • 213 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2015.

Based on Gotham Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.